__timestamp | Perrigo Company plc | Travere Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 4060800000 | 28203205 |
Thursday, January 1, 2015 | 4603900000 | 99892000 |
Friday, January 1, 2016 | 5280600000 | 133591000 |
Sunday, January 1, 2017 | 4946200000 | 154937000 |
Monday, January 1, 2018 | 4731700000 | 164246000 |
Tuesday, January 1, 2019 | 4837400000 | 175338000 |
Wednesday, January 1, 2020 | 5063300000 | 198321000 |
Friday, January 1, 2021 | 4138700000 | 227490000 |
Saturday, January 1, 2022 | 4451600000 | 212018000 |
Sunday, January 1, 2023 | 4655600000 | 145238000 |
Cracking the code
In the competitive landscape of pharmaceuticals, Perrigo Company plc and Travere Therapeutics, Inc. have showcased contrasting revenue trajectories over the past decade. From 2014 to 2023, Perrigo's revenue has consistently dwarfed that of Travere, with Perrigo averaging around 30 times more revenue annually. Perrigo's peak came in 2016, with a revenue surge of approximately 13% from 2014, while Travere's revenue growth was more modest, peaking in 2021 with an increase of over 700% from its 2014 figures.
Despite Perrigo's dominance, Travere's growth rate is noteworthy, reflecting its strategic focus on niche markets. As the industry evolves, these revenue trends highlight the diverse strategies and market positions of these two companies. Investors and industry watchers should keep an eye on how these dynamics play out in the coming years.
Eli Lilly and Company or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Gilead Sciences, Inc. vs Perrigo Company plc
Breaking Down Revenue Trends: BeiGene, Ltd. vs Perrigo Company plc
Comparing Revenue Performance: United Therapeutics Corporation or Perrigo Company plc?
Who Generates More Revenue? Ascendis Pharma A/S or Perrigo Company plc
Halozyme Therapeutics, Inc. and Travere Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Lantheus Holdings, Inc. vs Perrigo Company plc
Revenue Showdown: Perrigo Company plc vs Vericel Corporation
Perrigo Company plc and Mesoblast Limited: A Comprehensive Revenue Analysis
Bausch Health Companies Inc. vs Travere Therapeutics, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Taro Pharmaceutical Industries Ltd. vs Travere Therapeutics, Inc.
Revenue Insights: Travere Therapeutics, Inc. and Novavax, Inc. Performance Compared